Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

KEGG DRUG

DrugBank

Drug (Description in trials)

KEGG GENES

KEGG PATHWAY

Disease ID

1

Dabigatran etexilate 💬
(Dabigatran etexilate (USAN/INN))

[1] Dabigatran etexilate (Apo-dabigatran)

[1] Dabigatran etexilate

[1] F2 💬

[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬

[2] 51, 75 💬

2

Dabigatran 💬
(Dabigatran (USAN/INN))

[1] Dabigatran (Dabigatran)

[1] F2 💬

[8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬

[5] 51, 75, 85, 91, 124 💬